Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
AIDS (London, England)|August 15, 2014
Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohortPatricia Ndumbi, Jennifer Gillis, Janet M Raboud, et al.
JAMA|August 10, 2006
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisEdward J Mills, Jean B Nachega, Iain Buchan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian RegistryFernanda Q Onofrio, Curtis Cooper, Sergio M Borgia, et al.
Drug and Alcohol Dependence|February 25, 2014
Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection CohortJoseph Cox, Emilie Maurais, Lina Hu, et al.
BMJ Open|October 31, 2023
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccinationAlexa Keeshan, Yannick Galipeau, Aliisa Heiskanen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in CanadaGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
Trials|March 23, 2021
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trialDarrell H S Tan, Adrienne K Chan, Peter Jüni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapyDarrell H S Tan, Keith Chan, Janet Raboud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected PersonsLaurence Brunet, Erica E M Moodie, Jim Young, et al.
AIDS (London, England)|January 14, 2014
Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use historyAngela Cescon, Keith Chan, Janet M Raboud, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
AIDS (London, England)|August 15, 2014
Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohortPatricia Ndumbi, Jennifer Gillis, Janet M Raboud, et al.
JAMA|August 10, 2006
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisEdward J Mills, Jean B Nachega, Iain Buchan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian RegistryFernanda Q Onofrio, Curtis Cooper, Sergio M Borgia, et al.
Drug and Alcohol Dependence|February 25, 2014
Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection CohortJoseph Cox, Emilie Maurais, Lina Hu, et al.
BMJ Open|October 31, 2023
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccinationAlexa Keeshan, Yannick Galipeau, Aliisa Heiskanen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in CanadaGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
Trials|March 23, 2021
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trialDarrell H S Tan, Adrienne K Chan, Peter Jüni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapyDarrell H S Tan, Keith Chan, Janet Raboud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected PersonsLaurence Brunet, Erica E M Moodie, Jim Young, et al.
AIDS (London, England)|January 14, 2014
Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use historyAngela Cescon, Keith Chan, Janet M Raboud, et al.
Pageof 27